Wdzieczak-Bakala J - Search Results

1

New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities.

Keller L, Beaumont S, Liu JM, Thoret S, Bignon JS, Wdzieczak-Bakala J, Dauban P, Dodd RH. Keller L, et al. J Med Chem. 2008 Jun 26;51(12):3414-21. doi: 10.1021/jm701466p. Epub 2008 May 27. J Med Chem. 2008. PMID: 18503262

2

Isocombretastatins a versus combretastatins a: the forgotten isoCA-4 isomer as a highly promising cytotoxic and antitubulin agent.

Messaoudi S, Tréguier B, Hamze A, Provot O, Peyrat JF, De Losada JR, Liu JM, Bignon J, Wdzieczak-Bakala J, Thoret S, Dubois J, Brion JD, Alami M. Messaoudi S, et al. J Med Chem. 2009 Jul 23;52(14):4538-42. doi: 10.1021/jm900321u. J Med Chem. 2009. PMID: 19530698

3

Discovery of azaisoerianin derivatives as potential antitumors agents.

Soussi MA, Provot O, Bernadat G, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Brion JD, Messaoudi S, Alami M. Soussi MA, et al. Among authors: wdzieczak bakala j. Eur J Med Chem. 2014 May 6;78:178-89. doi: 10.1016/j.ejmech.2014.03.032. Epub 2014 Mar 13. Eur J Med Chem. 2014. PMID: 24681982

4

Synthesis of anti-microtubule biaryls and preliminary evaluation as vascular-disrupting agents.

Joncour A, Liu JM, Décor A, Thoret S, Wdzieczak-Bakala J, Bignon J, Baudoin O. Joncour A, et al. ChemMedChem. 2008 Nov;3(11):1731-9. doi: 10.1002/cmdc.200800181. ChemMedChem. 2008. PMID: 18785200

5

A novel iodomethylene-dimethyl-dihydropyranone induces G2/M arrest and apoptosis in human cancer cells.

Bignon J, Bénéchie M, Herlem D, Liu JM, Pinault A, Khuong-Huu F, Wdzieczak-Bakala J. Bignon J, et al. Anticancer Res. 2009 Jun;29(6):1963-9. Anticancer Res. 2009. PMID: 19528453 Free article.

6

Synthesis, biological evaluation of 1,1-diarylethylenes as a novel class of antimitotic agents.

Hamze A, Giraud A, Messaoudi S, Provot O, Peyrat JF, Bignon J, Liu JM, Wdzieczak-Bakala J, Thoret S, Dubois J, Brion JD, Alami M. Hamze A, et al. ChemMedChem. 2009 Nov;4(11):1912-24. doi: 10.1002/cmdc.200900290. ChemMedChem. 2009. PMID: 19790205

7

Discovery of isoerianin analogues as promising anticancer agents.

Messaoudi S, Hamze A, Provot O, Tréguier B, Rodrigo De Losada J, Bignon J, Liu JM, Wdzieczak-Bakala J, Thoret S, Dubois J, Brion JD, Alami M. Messaoudi S, et al. ChemMedChem. 2011 Mar 7;6(3):488-97. doi: 10.1002/cmdc.201000456. Epub 2011 Jan 14. ChemMedChem. 2011. PMID: 21360820

8

B-ring-modified isocombretastatin A-4 analogues endowed with interesting anticancer activities.

Hamze A, Rasolofonjatovo E, Provot O, Mousset C, Veau D, Rodrigo J, Bignon J, Liu JM, Wdzieczak-Bakala J, Thoret S, Dubois J, Brion JD, Alami M. Hamze A, et al. ChemMedChem. 2011 Dec 9;6(12):2179-91. doi: 10.1002/cmdc.201100325. Epub 2011 Oct 11. ChemMedChem. 2011. PMID: 21990101

9

Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: synthesis, cytotoxicity and antitubulin activity.

Rasolofonjatovo E, Provot O, Hamze A, Rodrigo J, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Brion JD, Alami M. Rasolofonjatovo E, et al. Eur J Med Chem. 2012 Jun;52:22-32. doi: 10.1016/j.ejmech.2012.03.001. Epub 2012 Mar 9. Eur J Med Chem. 2012. PMID: 22449653

10

Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors.

Aziz J, Brachet E, Hamze A, Peyrat JF, Bernadat G, Morvan E, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Tueni M, Yassine A, Brion JD, Alami M. Aziz J, et al. Org Biomol Chem. 2013 Jan 21;11(3):430-42. doi: 10.1039/c2ob26253c. Epub 2012 Oct 9. Org Biomol Chem. 2013. PMID: 23047722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page